Virtu Financial’s Sarepta Therapeutics SRPT Stock Holding History

Virtu Financial’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,901	Closed	-$542K	–	2104
2022 Q3	$542K	Buy	+4,901	New	+$494K	0.05%	362
2021 Q3	–	Sell	-5,612	Closed	-$436K	–	1932
2021 Q2	$436K	Sell	5,612 -4,974	-47%	-$377K	0.04%	540
2021 Q1	$789K	Buy	10,586 +7,142	+207%	+$659K	0.06%	321
2020 Q4	$587K	Buy	+3,444	New	+$510K	0.06%	389
2020 Q3	–	Sell	-2,725	Closed	-$437K	–	1482
2020 Q2	$437K	Buy	+2,725	New	+$371K	0.05%	413
2019 Q2	–	Sell	-4,027	Closed	-$480K	–	1840
2019 Q1	$480K	Sell	4,027 -7,213	-64%	-$927K	0.03%	580
2018 Q4	$1.23M	Buy	+11,240	New	+$1.41M	0.07%	227
2018 Q3	–	Sell	-3,873	Closed	-$512K	–	2152
2018 Q2	$512K	Sell	3,873 -4,984	-56%	-$470K	0.03%	778
2018 Q1	$656K	Buy	+8,857	New	+$591K	0.04%	558

Other funds holding SRPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu Financial's SRPT Position: Q4 2022 in Review

Virtu Financial sold out of Sarepta Therapeutics (SRPT) in Q4 2022, closing a stake of 4,901 shares — an estimated $542K sold.

Virtu Financial first reported a position in SRPT in Q1 2018 and held it in 9 quarters. The position peaked at $1.23M in Q4 2018. 411 funds tracked by Wall St. Rank hold SRPT as of Q4 2022.

Virtu Financial reported no remaining Sarepta Therapeutics position as of Q4 2022 after selling out during the quarter.
Virtu Financial sold 4,901 Sarepta Therapeutics shares in Q4 2022, an estimated $542K.
Virtu Financial first reported a position in Sarepta Therapeutics in Q1 2018 and held it in 9 quarters.
Virtu Financial's Sarepta Therapeutics position peaked at $1.23M in Q4 2018.
411 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2022.

Based on Virtu Financial's 13F filing for Q4 2022, filed 15 Feb 2023.